Live

treatment regimen /dose adjustments, special considerations and ADR management

Explain the opportunities to review TB-HIV collaborative activities at various forums, and levels.

Explain the PMDT review mechanism at various levels, crucial indicators to review, and different committees taking the onus of review.

What is it? Where kept? Who will update? What are the key information to be captured? when should it be updated? show the format.

Describe the form, discuss key information to be covered, who will update? What is the importance?

Describe the form, discuss key information to be covered, who will update? What is the importance?

The concept, manpower, treatment linkage and how they differ from ARTC.

Explain the DTCC, constitution, who heads?, Objectives, overall mandates and how it operates?

Term of Reference (ToR) and agenda for the TB-comorbidity committee, stakeholders and operations.

What is PMDT Treatment book? how it differs from treatment card and register? Describe the content, emphasising importent information. Who will initiate and who will update? Show the format.